Bisoprolol Fumarate Tablet, Film Coated
NDC Package 72888-233-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Bisoprolol Fumarate tablets is bisoprolol is used with or without other medications to treat high blood pressure (hypertension). This formulation utilizes a tablet, film coated delivery system. Marketed by Advagen Pharma Ltd, this product is identified by NDC 72888-233 and is authorized under FDA application ANDA075643.

Identification & Billing

NDC Package Code
72888-233-01
Package Description
30 TABLET, FILM COATED in 1 BOTTLE
Product Code
11-Digit Billing Format
72888023301
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Bisoprolol Fumarate
Non-Proprietary Name
Bisoprolol Fumarate
Substance Name
Bisoprolol Fumarate
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Bisoprolol is used with or without other medications to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This medication belongs to a class of drugs known as beta blockers. It works by blocking the action of certain natural chemicals in your body such as epinephrine on the heart and blood vessels. This effect lowers the heart rate, blood pressure, and strain on the heart.

Regulatory & Marketing

Labeler Name
Advagen Pharma Ltd
Product Type
Human Prescription Drug
FDA Application #
ANDA075643
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-07-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72888-233-01 identifies a specific commercial package of 30 tablet, film coated in 1 bottle of Bisoprolol Fumarate, a human prescription drug labeled by Advagen Pharma Ltd. This tablet, film coated is formulated for oral use and contains bisoprolol fumarate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Advagen Pharma Ltd on March 07, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Bisoprolol is used with or without other medications to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This medication belongs to a class of drugs known as beta blockers. It works by blocking the action of certain natural chemicals in your body such as epinephrine on the heart and blood vessels. This effect lowers the heart rate, blood pressure, and strain on the heart.

How is this Advagen Pharma Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72888023301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72888-233-01
11-Digit CMS (5-4-2)
72888-0233-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.